GRANTS
Molecular karyotype of tumor cells in Ph-negative acute lymphoblastic leukemia in adult patients: Influence on prognosis on the choice of therapy
Testing the hypothesis of immune privilege of bone marrow mesenchymal stem cells in a mouse model
Investigation of the involvement of the bone marrow niche regulating hematopoiesis in the development of relapses in patients with acute leukemia
CONTRACTS ON SCIENTIFIC AND TECHNICAL COOPERATION
Investigation of the T-cell immune response in peripheral blood mononuclear cell samples obtained during the clinical trial D8111C00003/CV03872097 "Simple blind randomized phase 1/2 trial to determine the safety and immunogenicity of a combination of AZD1222 and rAd26-S drugs administered under the "heterologous prime boost" scheme for the prevention of a new COVID-19 coronavirus infection in adults
Conducting the analytical part of a clinical trial for the drug PH-075 (INN: pembrolizumab) concentrate for the preparation of an infusion solution, 25 mg/ml, using a validated bioanalytical method
Development of draft regulatory documentation for the pharmaceutical substance "Cryo paste for fractionation from human blood plasma"
